These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11506745)

  • 1. Cytokines and cell surface receptors as target end points of immunosuppression with cyclosporine A.
    Sindhi R; Allaert J; Gladding D; Koppelman B; Dunne JF
    J Interferon Cytokine Res; 2001 Jul; 21(7):507-14. PubMed ID: 11506745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling individual variation in biomarker response to combination immunosuppression with stimulated lymphocyte responses-potential clinical implications.
    Sindhi R; Allaert J; Gladding D; Haaland P; Koppelman B; Dunne J; Sehgal S
    J Immunol Methods; 2003 Jan; 272(1-2):257-72. PubMed ID: 12505729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level.
    Andersson J; Nagy S; Groth CG; Andersson U
    Immunology; 1992 Jan; 75(1):136-42. PubMed ID: 1371491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.
    Berry V; Magill A; Yost M; Janosky J; Sindhi R
    Cytometry A; 2006 Feb; 69(2):95-103. PubMed ID: 16369935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes.
    Härtel C; Hammers HJ; Schlenke P; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
    J Interferon Cytokine Res; 2003 Feb; 23(2):91-9. PubMed ID: 12744774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.
    Puzik A; Schultz C; Iblher P; Müller-Steinhardt M; Härtel C
    Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells.
    Szabo G; Gavala C; Mandrekar P
    J Investig Med; 2001 Sep; 49(5):442-9. PubMed ID: 11523700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation.
    Baran J; Kowalczyk D; Ozóg M; Zembala M
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):303-13. PubMed ID: 11238213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A.
    Chi W; Yang P; Zhu X; Wang Y; Chen L; Huang X; Liu X
    Mol Vis; 2010 May; 16():880-6. PubMed ID: 20508866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytokine responses in liver transplant recipients treated with cyclosporine A and tacrolimus.
    Golling M; Sadeghi M; Zipperle S; Fonouni H; Golriz M; Mehrabi A
    Clin Transplant; 2009 Dec; 23 Suppl 21():83-91. PubMed ID: 19930321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression.
    Härtel C; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
    Clin Chem; 2002 Dec; 48(12):2225-31. PubMed ID: 12446480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes.
    Duperrier K; Velten FW; Bohlender J; Demory A; Metharom P; Goerdt S
    Mol Immunol; 2005 Aug; 42(12):1531-40. PubMed ID: 15950746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro.
    Batten P; McCormack AM; Page CS; Yacoub MH; Rose ML
    Transplantation; 1999 Nov; 68(10):1552-60. PubMed ID: 10589954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
    Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
    Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets.
    Tajima K; Amakawa R; Ito T; Miyaji M; Takebayashi M; Fukuhara S
    Immunology; 2003 Mar; 108(3):321-8. PubMed ID: 12603598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
    Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
    J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes.
    Rampino T; Ranghino A; Guidetti C; Gregorini M; Soccio G; Marasà M; Libetta C; Guida G; De Amici M; Dal Canton A
    Transpl Immunol; 2007 Jul; 18(1):32-6. PubMed ID: 17584600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclosporin A on inflammatory cytokine production by U937 monocyte-like cells.
    Garcia JE; de Cabo MR; Rodríguez FM; Losada JP; López AJ; Arellano JL
    Mediators Inflamm; 2000; 9(3-4):169-74. PubMed ID: 11132774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
    Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
    Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential immuno-suppressive effects of metabolic inhibitors on T-lymphocyte activation.
    Costello R; Mawas C; Olive D
    Eur Cytokine Netw; 1993; 4(2):139-46. PubMed ID: 8100456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.